RAD51 and cancer: In the current paper, we showed that B02 potentiates the anti-cancer activity of cisplatin invivo. Our data demonstrate that B02 inhibits formation of RAD51 foci in cancer tissues in mouse xenografts indicating that B02 acts through a targeted inhibition of RAD51 protein.